Login to Your Account

MGI Offering Could Gross $128M Following FDA Approval Of Aloxi

By Aaron Lorenzo

Tuesday, July 29, 2003
Capitalizing on a stock surge prompted by Friday's approval of a partnered cancer drug, MGI Pharma Inc. on Monday reported plans to sell 4 million shares. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription